Allergy & Immunology prior authorization at Elevance Health
PA workflow, documentation criteria, and peer-to-peer prep — for prescribers and PA staff
Elevance Health allergy & immunology PA at a glance
Elevance Health reviews allergy & immunology PA submissions against its medical policy library, with rules drawn primarily from AAAAI (American Academy of Allergy, Asthma & Immunology) + GINA for asthma + HAEA for HAE. Elevance Health-specific context: Operates Anthem BCBS in 14 states. Owns Carelon (formerly AIM) which manages utilization for specialty drugs and advanced imaging. State complaint route is to the state insurance department where the policy was issued.
Documentation packet — what to send
- Diagnosis with ICD-10 (severe asthma, CIU, AD, HAE)
- Biomarkers (eos, IgE, FeNO, C1-INH activity)
- Prior therapies tried
- Severity / attack-frequency documentation
Common denial patterns to pre-empt
Patterns observed in allergy & immunology across payers, and where Elevance Health's book of business overlaps:
- Asthma biologics: eosinophil / IgE / FeNO phenotyping not met
- Allergen immunotherapy: not tried before omalizumab in CIU
- Atopic dermatitis biologic: severity threshold not met
- Hereditary angioedema (HAE) prophylaxis: attack-frequency threshold not met
Appeal angles when Elevance Health denies
- GINA / AAAAI guideline citation
- Phenotype biomarker documentation (eos, IgE, FeNO)
- HAE: attack frequency documented over 3+ months pre-prophylaxis
Peer-to-peer prep
- Quote the AAAAI / GINA guideline
- For severe asthma biologic selection: match phenotype to drug (T2-high vs allergic vs eosinophilic)
- For HAE: bring attack-frequency log and C4 / C1-INH labs
- For CIU: document urticarial activity score (UAS7) trend
Drug-specific PA criteria at Elevance Health
Deep dives on each drug's PA criteria at Elevance Health:
Frequently asked questions
What documentation does Elevance Health need for allergy & immunology prior authorizations?
Elevance Health's PA packet for allergy & immunology typically includes: Diagnosis with ICD-10 (severe asthma, CIU, AD, HAE); Biomarkers (eos, IgE, FeNO, C1-INH activity); Prior therapies tried; Severity / attack-frequency documentation. AAAAI (American Academy of Allergy, Asthma & Immunology) + GINA for asthma + HAEA for HAE citations strengthen the submission.
What's the turnaround at Elevance Health?
Elevance Health standard decision: 30 days. Expedited (urgent care): 72 hours per 45 CFR §147.136. Internal appeal window if denied: 180 days.
Which allergy & immunology drugs does Elevance Health most often PA-restrict?
Top targets in allergy & immunology: dupilumab, omalizumab, mepolizumab, tezepelumab. Each follows the per-drug step therapy + documentation requirements published in Elevance Health's medical policy library.
How do I prep a peer-to-peer with Elevance Health in allergy & immunology?
Quote the AAAAI / GINA guideline For severe asthma biologic selection: match phenotype to drug (T2-high vs allergic vs eosinophilic) Have the policy URL and the patient's chart open before the call.
Generate a Allergy & Immunology PA packet
Open ApprovalHelp — generate a allergy & immunology PA packet tailored to Elevance Health's criteria, with prescriber attestation and supporting citations pre-filled.
Get started →Contact: hello@approvalhelp.com